You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alogliptin

Showing 1 - 25 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Guangzhou (SAL067, Alogliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Guangzhou, Guangdong, China
    1. Sun Yat-sen Memorial Hospital, Sun Yat-sen University,
Mar 21, 2023

Type 2 Diabetes Trial in China (Alogliptin, Acarbose, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • Alogliptin
  • +3 more
  • China, China
    CHINA
Apr 18, 2022

Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)

Completed
  • Healthy
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/500 mg, Alogliptin Benzoate 12.5 mg, Metformin HCl XR 500 mg)

Completed
  • Healthy
  • CT-L01 12.5/500 mg
  • +2 more
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Diabetes, Type 2 Trial in Korea, Republic of (Pioglitazone + Alogliptin, Alogliptin, Metformin)

Recruiting
  • Diabetes Mellitus, Type 2
  • Pioglitazone + Alogliptin
  • +3 more
  • Bucheon-si, Gyeonggi-do, Korea, Republic of
  • +14 more
Apr 7, 2022

Type 2 Diabetes Trial (Glimepiride, Alogliptin 25Mg Tab, Alogliptin-Pioglitazone 25 Mg-15 Mg Oral Tablet)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • (no location specified)
Oct 19, 2020

Alogliptin and Metformin Hydrochloride Combination Tablets

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Alogliptin and Metformin hydrochloride
  • Tokyo, Japan
    Takeda Selected Site
Oct 29, 2020

Nesina® Tablet Monotherapy or Combination Therapy in Type 2

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Alogliptin Benzoate
  • Andong, Korea, Republic of
  • +22 more
Mar 31, 2022

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting
  • Type 2 Diabetes Mellitus
  • Cardiovascular Diseases
  • Oakland, California
  • +5 more
Oct 18, 2022

Diabetes, Type 2 Trial in Worldwide (Alogliptin Benzoate, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Alogliptin Benzoate
  • Placebo
  • Little Rock, Arkansas
  • +54 more
Mar 14, 2022

Diabetes, Type 2 Trial in Catanzaro (Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy)

Recruiting
  • Diabetes Mellitus, Type 2
  • Metformin / alogliptin Oral Product
  • +2 more
  • Catanzaro, Italy
    ASP Catanzaro
Sep 11, 2020

Non-alcoholic Steatohepatitis, Type2 Diabetes Trial in Seoul (Nesinaact 25/15 (Alogliptin benzoate 25mg, pioglitazone HCl 15mg)

Unknown status
  • Non-alcoholic Steatohepatitis
  • Type2 Diabetes
  • Nesinaact 25/15 (Alogliptin benzoate 25mg, pioglitazone hydrochloride 15mg) treatment for 24 weeks
  • Seoul, Korea, Republic of
    Division of Geriatrics, Department of Internal Medicine, Yonsei
Oct 8, 2020

Surveillance: Mild Type 2 Diabetes Mellitus

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Alogliptin
  • Tokyo, Japan
    (unnamed)
Nov 12, 2019

"Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With

Completed
Has Results
  • Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
  • Alogliptin
  • Osaka, Japan
    (unnamed)
Nov 6, 2019

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Alogliptin
  • Osaka, Japan
  • +1 more
Oct 24, 2019

ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Active, not recruiting
  • Diabetes
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 3, 2023

Healthy Volunteers Trial in Yaroslavl (Alogliptin, Pioglitazone, SYR-322-4833 BL)

Completed
Has Results
  • Healthy Volunteers
  • Alogliptin
  • +2 more
  • Yaroslavl, Russian Federation
    Non-governmental healthcare Institution Road Clinical Hospital a
Jun 24, 2019

Alogliptin and Alogliptin Fixed-Dose Combinations With

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Alogliptin
  • +2 more
  • Beijing, Beijing, China
  • +10 more
Jan 23, 2019

NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Korea

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • NesinaAct® Tablet
  • Busan, Korea, Republic of
  • +7 more
Dec 14, 2021

Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)

Completed
  • Healthy
  • CT-L01 12.5/1,000 mg
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Diabetes, Type 2 Trial in Seoul (alogliptin+pioglitazone, alogliptin, pioglitazone)

Terminated
  • Diabetes Mellitus, Type 2
  • Seoul, Korea, Republic of
    Seoul St Mary's Hospital, The Catholic University of Korea
Jun 3, 2019

Alogliptin/Pioglitazone Combination Tablets Survey on Long-term

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Someplace, Japan
    (unnamed)
Aug 9, 2018

Type 2 Diabetes Trial in Seoul (alogliptin, Pioglitazone, alogliptin + pioglitazone)

Completed
  • Type 2 Diabetes Mellitus
  • alogliptin
  • +2 more
  • Seoul, Korea, Republic of
    Seoul St Mary's Hospital, The Catholic University of Korea
Feb 7, 2019

Type 2 Diabetes Trial in Naka-city (Trelagliptin, Alogliptin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Naka-city, Ibaragi, Japan
    (unnamed)
Dec 11, 2018